Board Comparison

FEBS-SO vs ABS-CGSO: Key Differences Between European and American Surgical Oncology Boards

Two certifications define surgical oncology excellence internationally: the FEBS-SO in Europe and the ABS-CGSO in the United States. This article compares them across every dimension that matters to a candidate — format, eligibility, guideline emphasis, and career implications.

Overview: Two Boards, One Discipline

Surgical oncology has two dominant supranational board certifications: FEBS-SO, issued by the European Union des Médecins Spécialistes (UEMS) in partnership with the European Society of Surgical Oncology (ESSO), and ABS-CGSO, issued by the American Board of Surgery (ABS) in collaboration with the Society of Surgical Oncology (SSO).

Both exams assess the same discipline — surgical oncology — and test many of the same clinical domains. Their differences reflect the distinct healthcare systems, regulatory frameworks, and guideline traditions in which they operate. Understanding these differences is essential for any surgical oncologist navigating international training or planning a career across borders.

Side-by-Side Comparison

Format: The Oral Examination Difference

The most consequential structural difference between the two boards is the oral examination. FEBS-SO requires candidates to pass both a written MCQ paper and a structured oral examination, typically conducted at the ESMO Congress in November. ABS-CGSO is written-only, with approximately 250 multiple-choice questions.

The FEBS-SO oral exam tests clinical reasoning in a way that written MCQ cannot fully replicate: candidates must defend management decisions, navigate ambiguous cases, and demonstrate fluency with European guideline frameworks under examiner scrutiny. The ABS-CGSO written exam compensates for the absence of an oral component with higher question volume and greater case complexity within the MCQ format.

Eligibility: Training Pathway Differences

FEBS-SO requires a national specialist qualification (equivalent to CCT in the UK) in surgery plus documented subspecialty surgical oncology training of at least 12 months. There is no single standardized accreditation body for European surgical oncology fellowships — programs vary by country — and ESSO membership is required.

ABS-CGSO eligibility is more precisely defined: candidates must hold ABS General Surgery certification and have completed a fellowship in an SSO-accredited program. The SSO accreditation system imposes standardized case volume and curriculum requirements, creating more uniformity across training sites than the European model currently provides.

Guideline Emphasis

The most clinically significant difference for exam preparation is guideline emphasis. FEBS-SO questions are written primarily to ESMO Clinical Practice Guidelines, with NCCN used as supplementary reference. ABS-CGSO questions are written primarily to NCCN Clinical Practice Guidelines, with ASCO and SSO/ASCO consensus documents as supplements.

In most clinical situations, ESMO and NCCN guidelines reach the same conclusion. Where they diverge — for example in the extent of lymphadenectomy for gastric cancer, the threshold for neoadjuvant chemotherapy in soft tissue sarcoma, or the role of HIPEC in colorectal peritoneal metastases — candidates must know which guideline their target board prioritizes.

Both boards use the AJCC Cancer Staging Manual 8th Edition as the standard TNM classification system. Staging knowledge is tested directly on both examinations.

Which Board Should You Pursue?

Recognition and Reciprocity

There is currently no formal reciprocity agreement between FEBS-SO and ABS-CGSO. Holding one certification does not grant exemption from the other's requirements. Some institutions — particularly those with international recruitment — recognise both boards as evidence of subspecialty competency, but this is at the discretion of the individual institution, not a regulatory standard.

Surgical oncologists with international careers may choose to sit both examinations. The content overlap is substantial enough that preparation for one board significantly reduces the study burden for the other. The principal additional preparation required is learning the guideline framework prioritized by the second board — ESMO if transitioning from ABS-CGSO preparation, NCCN if transitioning from FEBS-SO preparation.

One Question Bank for Both Boards

SurgBoardsQ&A was built to serve candidates preparing for both FEBS-SO and ABS-CGSO from a single platform. All 5,278 questions are tagged to both boards where applicable, with explanations that reference the relevant guideline for each — ESMO where FEBS-SO is the target, NCCN where ABS-CGSO is the target.

Filtering by board shows only questions relevant to the candidate's target examination. Questions that differ in correct answer between ESMO and NCCN are flagged explicitly, with both answers explained and the rationale for each guideline's position stated. No other surgical oncology question bank provides this dual-board mapping.